Gilead Sciences, Inc. (GILD) said the required waiting period under the HSR Act with respect to cash tender offer for CymaBay Therapeutics, Inc. expired on March 8, 2024. Unless the tender offer is extended, the offer and withdrawal rights will expire on March 21, 2024.
The expiration of the HSR waiting period satisfies one of the conditions to consummate the tender offer. The company noted that other conditions remain to be satisfied, include, among others, a minimum tender of shares of common stock of CymaBay representing a majority of the total number of outstanding shares of common stock of CymaBay.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.